CCS Research Awards
CCS-Bayer Resident Vascular Award
The CCS − Bayer Resident Vascular Award is open to Canadian clinical trainees (PGY 4-6) undertaking a research project on any topic related to thrombosis, anticoagulation, stroke or atrial fibrillation — particularly research that has the potential to advance knowledge about or improve the care of patients at risk for vascular thrombotic or embolic events.
Application deadline: TBD
CCS/HSRLCE/BI-Lilly Cardiometabolic Research Award
This Award is intended for Canadian clinical residents (PGY 4-6), or PhDs and MDs who are within five years of their first faculty appointment at a Canadian academic institution, for a research project on any topic related to cardiometabolic disease.
Applications deadline: TBD
Sponsored by the BMS-Pfizer alliance, the AF (Atrial Fibrillation) Research Awards support excellence in AF research and support promising Canadian early career researchers with an interest in AF.
Application deadline: TBD
CCS COVID-19 Challenge for Canada Initiative (CCS-C3I)
As the prevalence and outcomes of cardiovascular complications of COVID-19 remain poorly understood and uncharacterized, the aim of C3I is to empower the CCS clinician-scientist community to be prepared to harness emerging large-scale funds. By fostering multisite cardiovascular research across Canada, our CV community will be at the forefront of readiness for large-scale, CVD-related COVID-19 disease initiatives.
Application deadline: TBD